Atlas Trials

Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma

Clinical trial NCT03010358 · COMPLETED

Trial details

NCT number
NCT03010358
Sponsor
Alexey Danilov, MD
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
AnemiaB-Cell Prolymphocytic LeukemiaGrade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular LymphomaHairy Cell LeukemiaLymphoplasmacytic LymphomaMantle Cell LymphomaMarginal Zone LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Small Lymphocytic LymphomaRefractory Chronic Lymphocytic Leukemia
Start date
2017-07-17
Primary completion
2021-04-29
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.